Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Cross-section trichometry is an accurate method to measure hair loss and growth.

Certain gene variations may increase the risk of alopecia, and platelet-rich plasma treatment can improve hair density in those with hair loss; a rare case of facial Becker's nevus was linked to uneven beard growth.

The nanofibers with two growth factors improved wound healing by supporting structure, preventing infection, and aiding tissue growth.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

TGF-β is crucial for controlling stem cell behavior and changes in its signaling can lead to diseases like cancer.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Procyanidin compounds from grape seeds were found to significantly increase mouse hair growth.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

Decomposed tritiated thymidine is less accurate for DNA tracing, and hair changes can indicate malnutrition.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Smoking harms skin health, causing slower wound healing, more wrinkles, and worsening some skin conditions, but may protect against certain others.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Astaxanthin is a safe antioxidant that may improve heart, skin, eye health, and physical performance, and help manage chronic diseases.

Facial rejuvenation surgery makes people look younger, more attractive, successful, and healthy.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

COVID-19 may harm male fertility and damage the reproductive system.